Jeevan Kumar
Overview
Explore the profile of Jeevan Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biswas D, Basu D, Nag A, Kumar J, Datta S
Indian J Hematol Blood Transfus
. 2024 Oct;
40(4):710-714.
PMID: 39469163
Supplementary Information: The online version contains supplementary material available at 10.1007/s12288-024-01763-5.
2.
Rathod R, Sukumaran R, Kedia N, Kumar J, Nair R, Chandy M, et al.
Indian J Cancer
. 2024 Aug;
61(2):204-214.
PMID: 39152647
Using one's own immune system for curing cancer has been an active field of research in cancer biology and therapeutics. One such opportunity in cellular immunotherapy is adoptive cell transfers....
3.
Arunachala S, Devapal S, Swamy D, Greeshma M, Ul Hussain I, Siddaiah J, et al.
Indian J Crit Care Med
. 2024 Aug;
28(6):552-560.
PMID: 39130380
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. However, there is a lack of comprehensive data from low- and middle-income countries (LMICs) regarding...
4.
Shinde S, Guntiboina V, Nag A, Podder D, Chattopadhyay D, Kumar J, et al.
Blood Cell Ther
. 2024 Jun;
7(2):33-36.
PMID: 38854402
Melphalan-induced encephalopathy is a rare complication observed in patients undergoing autologous stem cell transplantation (ASCT) and is characterized by symptoms ranging from drowsiness to seizures. Previous reports have described similar...
5.
Arunachala S, Kumar J
Indian J Crit Care Med
. 2024 May;
28(5):422-423.
PMID: 38738194
Arunachala S, Kumar J. mNUTRIC Score in ICU Mortality Prediction: An Emerging Frontier or Yet Another Transient Trend? Indian J Crit Care Med 2024;28(5):422-423.
6.
Datta S, Agrawal S, Jain P, Kumar J, Bhattacharjee A, Bansal A, et al.
Ecancermedicalscience
. 2024 Feb;
17:1647.
PMID: 38414934
Despite the high cancer burden in low-middle-income-countries, medical students often have inadequate exposure to oncology. This may contribute to reduced interest in pursuing training in the field. The second ecancer...
7.
Kathrotiya M, Radhakrishnan V, Bhave S, Nag A, Arora N, Roychoudhry M, et al.
Indian J Cancer
. 2024 Jan;
60(4):486-492.
PMID: 38258869
Introduction: High-dose chemotherapy with melphalan, followed by autologous hematopoietic stem cell transplantation (AHCT) remains the standard of care for consolidation therapy of fit patients with newly diagnosed multiple myeloma (NDMM),...
8.
Kumar L, Melinkeri S, Ganesan P, Kumar J, Biswas G, Kilara N, et al.
Future Oncol
. 2023 Dec;
20(4):191-205.
PMID: 38116642
To assess the safety and effectiveness of daratumumab monotherapy in Indian patients with relapsed/refractory multiple myeloma. In this prospective, multicenter, phase IV study, patients (aged ≥18 years) received intravenous daratumumab...
9.
Pande S, Majethia P, Nair K, Rao L, Mascarenhas S, Kaur N, et al.
Eur J Hum Genet
. 2023 Dec;
32(10):1291-1298.
PMID: 38114583
The contribution of de novo variants as a cause of intellectual disability (ID) is well established in several cohorts reported from the developed world. However, the genetic landscape as well...
10.
Sardar S, Goel G, Ghosal A, Deshmukh R, Bhattacharya S, Haldar T, et al.
J Infect Dev Ctries
. 2023 Jul;
17(7):1037-1040.
PMID: 37515795
Cyclospora cayetanensis, a recently described coccidian parasite causes severe gastroenteric disease worldwide. Limited studies are found on the incidence of C. cayetanensis infection from India; hence remains largely unknown. To...